Diametric Capital’s Blueprint Medicines BPMC Stock Holding History

Diametric Capital’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,777	Closed	-$356K	–	390
2025 Q2	$356K	Buy	+2,777	New	+$288K	0.19%	151
2024 Q1	–	Sell	-4,571	Closed	-$422K	–	346
2023 Q4	$422K	Buy	+4,571	New	+$296K	0.26%	127

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Diametric Capital's BPMC Position: Q3 2025 in Review

Diametric Capital sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 2,777 shares — an estimated $356K sold.

Diametric Capital first reported a position in BPMC in Q4 2023 and held it in 2 quarters. The position peaked at $422K in Q4 2023. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Diametric Capital reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Diametric Capital sold 2,777 Blueprint Medicines shares in Q3 2025, an estimated $356K.
Diametric Capital first reported a position in Blueprint Medicines in Q4 2023 and held it in 2 quarters.
Diametric Capital's Blueprint Medicines position peaked at $422K in Q4 2023.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Diametric Capital's 13F filing for Q3 2025, filed 13 Nov 2025.